tiprankstipranks
Pharming Group Nv (PHAR)
NASDAQ:PHAR
Want to see PHAR full AI Analyst Report?

Compare Pharming Group (PHAR) vs. Competitors

201 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Pharming Group
$17.34
$1.19B
440.78
94.06%
3 Buy
0 Hold
0 Sell
Strong Buy
Trevi Therapeutics
$13.47
$1.97B
-42.49
101.01%
7 Buy
0 Hold
0 Sell
Strong Buy
Oric Pharmaceuticals
$10.75
$980.50M
-5.55
75.40%
10 Buy
0 Hold
0 Sell
Strong Buy
Praxis Precision Medicines
$342.50
$9.03B
-21.87
751.81%
14 Buy
1 Hold
1 Sell
Strong Buy
ARS Pharmaceuticals
$8.30
$849.98M
-6.70
-39.55%
3 Buy
0 Hold
0 Sell
Strong Buy
Prime Medicine, Inc.
$3.81
$615.68M
-2.57
95.98%
4 Buy
1 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
PHAR
Pharming Group
16.98
7.60
81.02%
TRVI
Trevi Therapeutics
13.87
6.97
101.01%
ORIC
Oric Pharmaceuticals
9.77
4.07
71.40%
PRAX
Praxis Precision Medicines
324.20
285.24
732.14%
SPRY
ARS Pharmaceuticals
8.56
-5.70
-39.97%
PRME
Prime Medicine, Inc.
3.41
1.84
117.20%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts